The purpose of the Hormone/Metabolite Core Laboratory is to make available to DERC investigators a variety of analytical techniques that are of interest in the study of diabetes, atherosclerosis, obesity, insulin resistance and related problems. The services provided are best based in a Core Laboratory because they require special instrumentation and methodology which would be difficult or impractically expensive to establish in the laboratories of the individual investigators who are Users of the DERC. The Hormone/Metabolite Core Laboratory has been in operation since 1980 as part of the New York Obesity Research Center (DERC). We now propose to broaden the research base ofthis Core by making it available to the Columbia University DERC. To this end, additional personnel are requested. In addition to being financially and technically expedient, the incorporation of the hormone/metabolite core in the DERC will facilitate scientific interactions between the diabetes research community in the Health Sciences campus and the New York Obesity Research Center at St. Luke's-Roosevelt Medical Center, an affiliated Hospital of Columbia University. The closer association has been encouraged by the leadership of Columbia University as a way of coordinating scientific efforts, while maximizing utilization of existing resources and reducing the need for additional facilities, an expensive commodity in Manhattan. The record of this core as part of the NYORC suggests that it will be an important asset of the Columbia DERC.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
1P30DK063608-01
Application #
6612245
Study Section
Special Emphasis Panel (ZDK1-GRB-7 (O1))
Project Start
2002-09-01
Project End
2007-08-31
Budget Start
Budget End
2004-01-31
Support Year
1
Fiscal Year
2003
Total Cost
$95,100
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Savage, Thomas M; Shonts, Brittany A; Obradovic, Aleksandar et al. (2018) Early expansion of donor-specific Tregs in tolerant kidney transplant recipients. JCI Insight 3:
Molusky, Matthew M; Hsieh, Joanne; Lee, Samuel X et al. (2018) Metformin and AMP Kinase Activation Increase Expression of the Sterol Transporters ABCG5/8 (ATP-Binding Cassette Transporter G5/G8) With Potential Antiatherogenic Consequences. Arterioscler Thromb Vasc Biol 38:1493-1503
Carpenter, D J; Granot, T; Matsuoka, N et al. (2018) Human immunology studies using organ donors: Impact of clinical variations on immune parameters in tissues and circulation. Am J Transplant 18:74-88
Langlet, Fanny; Tarbier, Marcel; Haeusler, Rebecca A et al. (2018) microRNA-205-5p is a modulator of insulin sensitivity that inhibits FOXO function. Mol Metab 17:49-60
Proto, Jonathan D; Doran, Amanda C; Gusarova, Galina et al. (2018) Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution. Immunity 49:666-677.e6
Carli, Jayne F Martin; LeDuc, Charles A; Zhang, Yiying et al. (2018) The role of Rpgrip1l, a component of the primary cilium, in adipocyte development and function. FASEB J 32:3946-3956
Postigo-Fernandez, Jorge; Creusot, RĂ©mi J (2018) A multi-epitope DNA vaccine enables a broad engagement of diabetogenic T cells for tolerance in Type 1 diabetes. J Autoimmun :
Proto, Jonathan D; Doran, Amanda C; Subramanian, Manikandan et al. (2018) Hypercholesterolemia induces T cell expansion in humanized immune mice. J Clin Invest 128:2370-2375
Martin Carli, Jayne F; LeDuc, Charles A; Zhang, Yiying et al. (2018) FTO mediates cell-autonomous effects on adipogenesis and adipocyte lipid content by regulating gene expression via 6mA DNA modifications. J Lipid Res 59:1446-1460
Arnes, Luis; Liu, Zhaoqi; Wang, Jiguang et al. (2018) Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma. Gut :

Showing the most recent 10 out of 225 publications